Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
Therapeutic Drug Monitoring|May 17, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With ObesityMaria-Stephanie A Hughes, Jasmine H Hughes, Jeffrey Endicott, et al.
Clinical Pharmacology and Therapeutics|October 17, 2020
Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of VancomycinJasmine H Hughes, Dominic M H Tong, Sarah Scarpace Lucas, et al.
Frontiers in Pharmacology|December 24, 2021
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Ron J Keizer, Janel R Long-Boyle, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Model-based treatment optimization of a novel VEGFR inhibitorRon J Keizer, Anubha Gupta, Robert Shumaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neckD ten Bokkel Huinink, M E Tesselaar, R J Baatenburg de Jong, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2012
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot studyRobert S Jansen, Hilde Rosing, Pierre W Wijermans, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 24, 2007
[The pharmacokinetics of monoclonal antibodies]R J Keizer, A D R Huitema, C W N Damen, et al.
Journal of Pharmaceutical Sciences|December 7, 2013
Development of an extended-release formulation of capecitabine making use of in vitro-in vivo correlation modellingJelte Meulenaar, Ron J Keizer, Jos H Beijnen, et al.
Pageof 21